Results 81 to 90 of about 3,490 (198)

Estudio de concordancia y equivalencia entre los cuestionarios Barthel, Lawton, HAQ y BASFI en pacientes con artritis reumatoide y espondiloartritis [PDF]

, 2018
Treball Final de Grau en Medicina. Codi: MD1158. Curs acadèmic: 2017/2018Background: Due to the chronic and invalidating nature of rheumatic diseases, which affect the quality of life, it
Copoví Moya, María
core  

Integration of Metabolomics and 16S Ribosomal RNA Sequencing to Elucidate the Pathogenesis of Ankylosing Spondylitis

Immunity, Inflammation and Disease, Volume 13, Issue 3, March 2025.
Disrupted gut microbiota and altered metabolites are present in AS patients. The analysis of microbiome and metabolomic data revealed significant differences between AS patients and HCs. ABSTRACT Objective Despite growing interest in the gut microbiota and blood metabolome in patients with ankylosing spondylitis (AS), its role remains poorly understood.
Xin Wang, Haojie Xu, Yuyan Chao, Chao Sun, Tingting Wang, Xiaoyun Fan, Lin Tang, Shengqian Xu, Changhao Xie   +8 more
wiley   +1 more source

A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines?

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 3, Page 512-528, March 2025.
Abstract Background Gender‐ and sex‐specific differences in medicine were long‐time disregarded. Despite numerous indications of gender‐ and sex‐specific influences on the treatment of dermatological conditions, these have not yet been systematically investigated.
S. Preis, S. Ziehfreund, T. Biedermann, S. Horster, A. Zink   +4 more
wiley   +1 more source

Fatiga en pacientes con espondiloartritis: datos en un centro de atención terciaria en Brasil

Revista Argentina de Reumatología
Introducción: la fatiga es frecuente en los pacientes con espondiloartritis axial (SpA), afectando la calidad de vida y su causa no es completamente comprendida. Objetivos: estudiar factores asociados a fatiga en pacientes con SpA.
Thelma Larocca Skare, Milena Weber Schiller, Thayná Siqueira Lipienski, Ana Paula Beckhauser, Juliana Simioni, Renato Nisihara   +5 more
doaj   +1 more source

Peripheral arthritis and higher disease activity lead to more functional impairment in axial spondyloarthritis: Longitudinal analysis from ESPAXIA

, 2021
Objetive: The aim of this study was to investigate whether peripheral arthritis together with disease activity independently contribute to functional impairment over time in patients with axSpA and to evaluate if there are contextual factors modifying ...
Schneeberger, E.E., Capelusnik, D., Citera, G., Ramiro, S.   +3 more
core   +1 more source

Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo‐Controlled, Phase 3 Study

Arthritis &Rheumatology, Volume 77, Issue 2, Page 163-170, February 2025.
Objective Our goal was to assess the efficacy and safety of intravenous (IV) secukinumab for the treatment of adults with active axial spondyloarthritis (axSpA) in INVIGORATE‐1. Methods INVIGORATE‐1 (NCT04156620) was a randomized, double‐blind, parallel‐group, phase 3 trial in patients with active axSpA (either radiographic or nonradiographic ...
Atul Deodhar, Jerzy Supronik, Alan Kivitz, Guillermo Valenzuela, Karen Kapur, Susanne Rohrer, Eva Dokoupilová, Hanno B. Richards, Karel Pavelka   +8 more
wiley   +1 more source

Predictors of therapeutic response in ankylosing spondylitis patients initiating therapy with adalimumab in a german non-interventional study

, 2022
2847Background/Purpose: Ankylosing spondylitis (AS) is associated with a significant burden of illness and has limited treatment options. The identification of predictors of response to anti-tumor necrosis factor (TNF) therapy may help clinicians select ...
Scharbatke, E.C., Greger, G., Gnann, H., Burkhardt, H., Schmalzing, M., Koehm, M., Tony, H.P., Wittig, B., Behrens, F.   +8 more
core  

Additional file 1 of Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?

, 2023
Additional file 1: Supplementary Table 1. Predictors of Sustained Low BASFI (
Proton Rahman (192262), Louis Bessette (3437222), Allen J. Lehman (9398010), Walter P. Maksymowych (11879423), Emmanouil Rampakakis (210135), Anne Marilise Marrache (15376315), Meagan Rachich (15376312), Robert D. Inman (8597190), Odalis Asin-Milan (15376309)   +8 more
core   +1 more source

When Usual Care Is Not So Usual: Protocol Violations and Generalizability in a Treat‐to‐Target Strategy Trial in Patients With Axial Spondyloarthritis

Arthritis Care &Research, Volume 76, Issue 11, Page 1540-1548, November 2024.
Objective The objective of this study was to evaluate the impact of protocol violations in the treat‐to‐target group in the Tight Control in Spondyloarthritis (TICOSPA) trial and to compare the proportion of patients optimally treated according to the Assessment of Spondyloarthritis International Society (ASAS)/EULAR 2016 recommendations for patients ...
Clementina López‐Medina, Filip van den Bosch, Désirée van der Heijde, Maxime Dougados, Anna Molto   +4 more
wiley   +1 more source

Bone Mineral Density in Ankylosing Spondylitis

Türk Osteoporoz Dergisi, 2003
Ankylosing Spondylitis (AS), a chronic inflammatory rheumatic disease. One of the most frequent and important complications in these patients is osteoporosis.
Bahar Çakmak, Hidayet Sarı
doaj